Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|June 29, 2020
J&J to Stop Selling Skin Lightening Products
Author(s)Katie Hobbins
This week, consumer magazines highlight cellulite tips and tricks, skin cancer in POC and more.
Advertisement
In this week’s Patient Insight, Elle discusses Johnson & Johnson’s decision to stop selling skin lightening creams overseas, Cosmopolitan details keratosis pilaris treatments and tips to get rid of cellulite, and InStyle talks controversial oxybenzone in sunscreen and skin cancer in people of color.
Skin
Body
Melanoma
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
4
Skin Longevity Needs Evidence, Not Hype
5